Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Azra Mahmud & John Feely. (2003) Antihypertensive drugs and arterial stiffness. Expert Review of Cardiovascular Therapy 1:1, pages 65-78.
Read now
Read now
Articles from other publishers (21)
Abdelrahman Abushouk, Tikal Kansara, Omar Abdelfattah, Osamah Badwan, Essa Hariri, Pulkit Chaudhury & Samir R. Kapadia. (2023) The Dicrotic Notch: Mechanisms, Characteristics, and Clinical Correlations. Current Cardiology Reports 25:8, pages 807-816.
Crossref
Crossref
Reem Alsharari, Gregory Y H Lip & Alena Shantsila. (2020) Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?. American Journal of Hypertension 33:2, pages 107-115.
Crossref
Crossref
Aros Dlawer Barzenje, Knut Gjesdal, Bendik Slagsvold Winsvold, Milada Cvancarova Småstuen, Lars Jacob Stovner, Gøril Bruvik Gravdahl & Kristian Bernhard Nilsen. (2020) Clinical and vascular responses to propranolol and candesartan in migraine patients: A randomized controlled clinical trial. Cephalalgia Reports 3, pages 251581632094649.
Crossref
Crossref
Seung-Suk Kim. (2017) Effects of endurance exercise and half-bath on body composition, cardiorespiratory system, and arterial pulse wave velocity in men with intellectual disabilities. Journal of Physical Therapy Science 29:7, pages 1216-1218.
Crossref
Crossref
Alberto Milan, Francesco Tosello, Ambra Fabbri, Alessandro Vairo, Dario Leone, Michela Chiarlo, Michele Covella & Franco Veglio. (2011) Arterial Stiffness. High Blood Pressure & Cardiovascular Prevention 18:1, pages 1-12.
Crossref
Crossref
Els Moltzer, Francesco U.S. Mattace Raso, Yusuf Karamermer, Eric Boersma, Gary D. Webb, Maarten L. Simoons, A.H. Jan Danser, Anton H. van den Meiracker & Jolien W. Roos-Hesselink. (2010) Comparison of Candesartan Versus Metoprolol for Treatment of Systemic Hypertension After Repaired Aortic Coarctation. The American Journal of Cardiology 105:2, pages 217-222.
Crossref
Crossref
Sarah A Hope & Alun D Hughes. (2007) DRUG EFFECTS ON THE MECHANICAL PROPERTIES OF LARGE ARTERIES IN HUMANS. Clinical and Experimental Pharmacology and Physiology 34:7, pages 688-693.
Crossref
Crossref
Enrico Agabiti-Rosei, Maria Muiesan & Damiano Rizzoni. 2006. Angiotensin II Receptor Antagonists. Angiotensin II Receptor Antagonists
111
126
.
Carole L. Turner, Ian B. Wilkinson & Peter J. Kirkpatrick. (2006) Use of antihypertension agents for the suppression of arterial pulse pressure waveforms in patients with intracranial aneurysms. Journal of Neurosurgery 104:4, pages 531-536.
Crossref
Crossref
Eigil Fossum, Michael Hecht Olsen, Aud Høieggen, Kristian Wachtell, Henrik M. Reims, Sverre E. Kjeldsen, Hans Ibsen, Ying Wan & Stevo Julius. (2007) Long‐Term Effects of a Losartan‐Compared With an Atenolol‐Based Treatment Regimen on Carotid Artery Plaque Development in Hypertensive Patients With Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy. The Journal of Clinical Hypertension 8:3, pages 169-173.
Crossref
Crossref
Samer S. Najjar & Edward G. Lakatta. 2005. Principles of Molecular Cardiology. Principles of Molecular Cardiology
517
547
.
G S Stergiou. (2004) Angiotensin receptor blockade in the challenging era of systolic hypertension. Journal of Human Hypertension 18:12, pages 837-847.
Crossref
Crossref
Azra MahmudJohn Feely. (2016) Review: Arterial stiffness and the renin-angiotensin-aldosterone system. Journal of the Renin-Angiotensin-Aldosterone System 5:3, pages 102-108.
Crossref
Crossref
M G Nicholls. (2004) LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?. Journal of Human Hypertension 18:5, pages 295-300.
Crossref
Crossref
George S. Stergiou, Stamatis P. Efstathiou, Leonidas G. Roussias & Theodore D. Mountokalakis. (2003) Blood Pressure- and Pulse Pressure-Lowering Effects, Trough:Peak Ratio and Smoothness Index of Telmisartan Compared with Lisinopril. Journal of Cardiovascular Pharmacology 42:4, pages 491-496.
Crossref
Crossref
Samy I McFarlane, Ashok Kumar & James R Sowers. (2003) Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. The American Journal of Cardiology 91:12, pages 30-37.
Crossref
Crossref
GS Stergiou, SP Efstathiou, II Skeva, NM Baibas, CB Kalkana & TD Mountokalakis. (2002) Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. Journal of Human Hypertension 16:10, pages 729-735.
Crossref
Crossref
Malte Ludwig, Manfred Stapff, Artur Ribeiro, Emanuel Fritschka, Ulrich Tholl, Ronald D. Smith & Klaus O. Stumpe. (2002) Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clinical Therapeutics 24:7, pages 1175-1193.
Crossref
Crossref
Nathaniel Winer, Michael A. Weber & James R. Sowers. (2001) The effect of antihypertensive drugs on vascular compliance. Current Hypertension Reports 3:4, pages 297-304.
Crossref
Crossref
Michael S. Berlowitz, Farhana Latif, Shelley R. Hankins, Pierre Vladimir Ennezat, Robert Moskowitz, Suman Tandon, Paolo C. Colombo & Thierry H. Le Jemtel. (2001) Dose-Dependent Blockade of the Angiotensin II Type 1 Receptor with Losartan in Normal Volunteers. Journal of Cardiovascular Pharmacology 37:6, pages 692-696.
Crossref
Crossref
Helmy M. Siragy & Robert M. Carey. (2001) Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Current Opinion in Nephrology and Hypertension 10:1, pages 99-103.
Crossref
Crossref